AdvaMedDx VALID Act Comments Overview
application/pdf
- 100.79 kB
Date:
02/15/2019 Disease Area:
Comments
AdvaMedDx Comments on FDA Technical Assistance (TA) on Diagnostic Accuracy and Innovation Act (DAIA) House Discussion Draft
application/pdf
- 695.21 kB
Date:
08/27/2018 Disease Area:
AdvaMed Comments on Docket No. FDA-2018-D-0944; Draft Guidance for Industry; Investigational In Vitro Diagnostics in Oncology Trials: Streamlined Submission Process for Study Risk Determination
application/pdf
- 788.49 kB
Date:
06/25/2018 Disease Area:
Comments to FDA on Select Updates for Recommendations for CLIA of 1988 Waiver Applications for Manufacturers of IVD Devices
application/pdf
- 965.08 kB
Date:
03/28/2018 Disease Area:
AdvaMedDx Comments on Preliminary Payment Rates Based on Private-Payer Data under PAMA 216
application/pdf
- 486.94 kB
Date:
10/24/2017 Disease Area:
AdvaMedDx Comments on Draft Guidance for Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices
application/pdf
- 683.04 kB
Date:
11/29/2016 Disease Area:
AdvaMedDx Statement at CMS Clinical Laboratory Public Meeting July 2015
application/pdf
- 203.73 kB
Date:
07/16/2015 Disease Area:
AdvaMedDx Comments to 21st Century Cures Request for Feedback
application/pdf
- 511.25 kB
Date:
01/05/2015 Disease Area:
AdvaMed Outpatient Prospective Payment System Comments
application/pdf
- 8.34 MB
Date:
09/06/2013 Disease Area:
AdvaMed Physician Fee Schedule Comments
application/pdf
- 1.02 MB
Date:
09/06/2013 Disease Area: